Fragmentation of Nimotuzumab for Preparation of  125 I-F(ab’) 2- Nimotuzumab as a Precursor for Preparing  125 I-F(ab’) 2- Nimotuzumab-NLS Radiopharmaceutical for Cancer Therapy

R.D. Haryuni; A. Bahtiar; S. Soenarjo; Y. Harahap; A. Mutalib; M. Ramli; S. Hermanto; C.N. Ardiyatno; V.Y. Susilo; D. Haffid

2023CiteScore

34th percentile

User

About The Authors

R.D. Haryuni
Department of Pharmacy, Faculty of Pharmacy, University of Indonesia, Depok 16424, Indonesia Centre for Radioisotopes and Radiopharmaceuticals Technology, National Nuclear Energy Agency, Puspiptek Area Serpong, Tangerang 15310, Indonesia
Indonesia

A. Bahtiar
Department of Pharmacy, Faculty of Pharmacy, University of Indonesia, Depok 16424, Indonesia
Indonesia

S. Soenarjo
Centre for Radioisotopes and Radiopharmaceuticals Technology, National Nuclear Energy Agency, Puspiptek Area Serpong, Tangerang 15310, Indonesia
Indonesia

Y. Harahap
Department of Pharmacy, Faculty of Pharmacy, University of Indonesia, Depok 16424, Indonesia
Indonesia

A. Mutalib
Department of Chemistry, Faculty of Mathematics and Natural Science, Padjajaran University, Bandung 40133, Indonesia
Indonesia

M. Ramli
Centre for Radioisotopes and Radiopharmaceuticals Technology, National Nuclear Energy Agency, Puspiptek Area Serpong, Tangerang 15310, Indonesia
Indonesia

S. Hermanto
Department of Chemistry, Faculty of Science and Technology, Syarif Hidayatullah State Islamic University Jakarta, Jl. Ir. Haji Juanda, Tangerang 15412, Indonesia
Indonesia

C.N. Ardiyatno
Centre for Radioisotopes and Radiopharmaceuticals Technology, National Nuclear Energy Agency, Puspiptek Area Serpong, Tangerang 15310, Indonesia
Indonesia

V.Y. Susilo
Centre for Radioisotopes and Radiopharmaceuticals Technology, National Nuclear Energy Agency, Puspiptek Area Serpong, Tangerang 15310, Indonesia
Indonesia

D. Haffid
Centre for Radioisotopes and Radiopharmaceuticals Technology, National Nuclear Energy Agency, Puspiptek Area Serpong, Tangerang 15310, Indonesia
Indonesia

Article Tools